Skip to content

Effects of NMES on Energy Expenditure, Glycaemia and Hormonal Responses to Glucose Ingestion

Effects of Self-selected Maiximal Intensity of Neuromuscular Electrical Stimulation (NMES) on Energy Expenditure, Glycaemia and Hormonal Responses on Healthy Individuals

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04389736
Enrollment
9
Registered
2020-05-15
Start date
2018-11-27
Completion date
2019-01-20
Last updated
2020-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Energy Expenditure, Metabolic Health

Keywords

Neuromuscular electrical stimulation, Insulin resistance, Standing, Glucose control

Brief summary

The purpose of this study is to investigate whether self-selected neuromuscular stimulation (NMES) affects energy expenditure, glycaemia and hormonal responses in healthy men and women

Detailed description

Participants were asked to perform 3 trials \[sitting (SIT), standing (STAND) and sitting with neuromuscular electrical stimulation (NMES) to the lower limbs in randomised counter-balanced study design. Trials were separated by at least 48 h and were completed within 14 days. In all trials, participants were required to remain relaxed and motionless. SIT: participants sat in a chair with back, arms and legs supported. STAND: participants were asked to stand with arms supported and feet spaced approximately 15 cm apart. If needed, adjustment of standing posture was allowed during the standing trial to prevent orthostatic hypotension. NMES: prior to the NMES trial, participants underwent preliminary testing to ensure that stimulation was comfortable. Before the NMES, a small area of the body hair was shaved and skin was cleaned with an alcohol wipe and electrodes were stuck to the surface of the skin. Small electrodes placed (5\*5 cm) on the lower limb of both legs (gastrocnemius, rectus femoris, vastus medialis). The two devices (EM 80, Beurer UK Ltd, Golborne, UK) were set up with the frequency of 20 Hz along with stimulation period of 1 second on and 1 second off throughout a 2 h oral glucose tolerance test (OGTT). The instruction for NMES intensity was that the maximal intensity participants were be able to withstand for 2 hours whilst imagining sitting at home watching TV without feeling discomfort. Prior to the OGTT, 5 min was given to identify the suitable intensity of stimulation and within the first 10 min of the OGTT participants were allowed to adjust the intensity once, after which, the intensity remained the same for the rest of OGTT. Participants were asked to sit in a chair with back, arms and legs supported during the stimulation. During trials, participants could watch TV, or read, but typing on a laptop or computer were avoided.

Interventions

BEHAVIORALSitting

Participants sat in a chair with back, arms and legs supported.

BEHAVIORALStanding

Participants were asked to stand with arms supported and feet spaced approximately 15 cm apart. If needed, adjustment of standing posture was allowed during standing trial to prevent orthostatic hypotension.

BEHAVIORALSelf-selected maximal intensity of neuromuscular electrical stimulation

Small electrodes placed (5\*5 cm) on the lower limb of both legs. The instruction for NMES intensity was that the maximal intensity participants were be able to withstand for 2 hours whilst imagining sitting at home watching TV without feeling discomfort.

Sponsors

University of Bath
CollaboratorOTHER
National Taiwan Normal University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy men and women * Aged between 18 to 65 years * Weight stable for more than 3 months (no change in weight +/- 3%) * Non-smoker

Exclusion criteria

* Personal history of/existing diabetes, cardiovascular disease, metabolic disease or dyslipidaemia * Taking medications that may influence lipid or carbohydrate metabolism or immune system function

Design outcomes

Primary

MeasureTime frameDescription
Changes in total energy expenditure during OGTT test.120 minutesChanges in total energy expenditure during OGTT test.

Secondary

MeasureTime frameDescription
Changes in blood insulinaemic responses during OGTT test.120 minutesChanges in blood insulinaemic responses during OGTT test.
Changes in blood pressure during OGTT test.120 minutesChanges in blood pressure during OGTT test.
Changes in heart rate during OGTT test.120 minutesChanges in heart rate during OGTT test.
Changes in blood glycaemic responses during OGTT test.120 minutesChanges in blood glycaemic responses during OGTT test.
Changes in total carbohydrate during OGTT test.120 minutesChanges in total carbohydrate during OGTT test.
Changes in total lipid oxidation during OGTT test.120 minutesChanges in total lipid oxidation during OGTT test.
Changes in gut hormones (GLP-1, GIP & PYY etc.) responses during OGTT test.120 minutesChanges in gut hormones (GLP-1, GIP & PYY etc.) responses during OGTT test.

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026